Deckers Outdoor stock falls 14% as raised guidance falls short of expectations, facing headwinds from strong dollar and ...

BTIG lowered the firm’s price target on PulteGroup (PHM) to $145 from $156 and keeps a Buy rating on the shares. The company’s EPS beat was ...

BTIG analyst Vincent Caintic maintained a Hold rating on Bread Financial Holdings (BFH – Research Report) today. The company’s shares closed ...

BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...

BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering ...

BTIG Research has recently raised Instacart (CART) stock to Buy rating, as announced on January 14, 2025, according to Finviz. Earlier, on January 14, 2025, Mizuho had initiated the stock to ...

BTIG Research has recently reduced Plug Power Inc (PLUG) stock to Neutral rating, as announced on November 14, 2024, according to Finviz. Earlier, on April 5, 2024, Citigroup had reduced the stock ...

But before that let's have a chartist view from BTIG's technical guru Jonathan Krinsky. He notes that the S&P 500's rally off this week's lows is quite impressive and sets up the stock barometer ...

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment rating to "Neutral" from "Buy" on Tuesday. The research firm said its ...

On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company's lead product, ANKTIVA, an IL-15 receptor ...

In light of these considerations, Zelin updated BTIG's model to reflect a more moderate differentiation of briquilimab versus barzolvolimab and the decreased likelihood of a Q12W regimen. Despite the ...